Results
1
1 companies
Revenio Group Oyj
Market Cap: €337.4m
Provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally.
REG1V
€12.52
7D
-1.9%
1Y
-54.1%